Publications by authors named "Junping Shi"

Claim this Profile
T
Two-Step Machine Learning Model Enhances Identification of High-Risk Metabolic Dysfunction-Associated Steatotic Liver Disease.
Zheng'ao Xu, Yongfen Zhu, Fengjuan Chen, Qiongyue Fan, Ruiqi Wang, Junping Shi

Liver Int· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cells in metabolic dysfunction-associated steatotic liver disease (MASLD): From mechanisms to therapeutic exploration.
Leyao Jia, Xue Bai, Wenjing Ni, Shengxia Yin, Junping Shi

Int Immunopharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter Study.
Jing Zhao, Ferenc E Mózes, Xin-Yu Xu, Dong Ji, Huiqing Liang, Takeshi Okanoue, Toshihide Shima, Atsushi Nakajima, Junping Shi

MedComm (2020)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrotic MASH resolution index to diagnose fibrotic MASH resolution and predict LREs: A global multicenter study.
Gong Feng, Jérôme Boursier, Marc de Saint Loup, Yusuf Yilmaz, Hirokazu Takahashi, Hiroshi Isoda, Junping Shi, Atsushi Nakajima

Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear Factor I-B Delays Liver Fibrosis by Inhibiting Chemokine Ligand 5 Transcription.
Qianqian Chen, Fajuan Rui, Zhiwen Fan, Hongju Yang, Nan Geng, Junping Shi

Adv Sci (Weinh)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BIGH3 as a potential biomarker for fibrosis in metabolic dysfunction-associated steatotic liver disease: insights from mouse and human studies.
Zhenjie Zhuang, Fen Zhuge, Yinlan Liu, Yu Song, Yan Luo, Junping Shi

BMC Gastroenterol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Liver fat mediates hippocampal-orbitofrontal reward circuit disruption and cognitive-emotional impairments in MASLD.
Liqiang Wu, Ruoyu Tang, Yidan Liang, Yihan Jin, Kuanghui Xu, Junping Shi

Lipids Health Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD).
Qianqian Chen, Yixuan Zhu, Jingli Gao, Wenjing Ni, Shanghao Liu, Junping Shi

Commun Med (Lond)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between liver fat, pancreatic fat, and new-onset type 2 diabetes mellitus in patients with metabolic dysfunction-associated fatty liver disease.
Huanjia Qu, Lingling Zhou, Dong Tang, Qiuling Zhang, Pu Yang, Junping Shi

Acta Diabetol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review Article: Impact of Alcohol Consumption on the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease.
Yunxuan Lei, Yixuan Zhu, Wenjing Ni, Junping Shi, Wai-Kay Seto

Aliment Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early elevation of complement-related proteins in metabolic dysfunction-associated steatotic liver disease (MASLD) with normal liver enzymes.
Li Shao, Binbin Zhang, Jing Liu, Zhe Lyu, Weishi Zhang, Junping Shi

BMC Gastroenterol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Health-Related Quality of Life and Its Influencing Factors Among Patients with Non-Alcoholic Fatty Liver Disease in Hangzhou, China: A Cross-Sectional Study.
Han Fei, Kexin Lv, Jiayin Xu, Haojie Hao, Yidan Quan, Junping Shi

Metab Syndr Relat Disord· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver fat mediates hippocampal-orbitofrontal reward circuit disruption and cognitive-emotional impairments in MASLD.
Liqiang Wu, Ruoyu Tang, Yidan Liang, Yihan Jin, Kuanghui Xu, Junping Shi

Lipids Health Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bidirectional crosstalk of the gut-liver axis in metabolic dysfunction-associated steatotic liver disease.
Juan Zhang, Xin Tong, Wei Lin, Rahma Issa, Lijuan Wang, Junping Shi

Chin Med J (Engl)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of machine learning and deep learning in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.
Huan Zhang, Xiangyu Wu, Wenjing Ni, Jiali Wu, Sisi Zhou, Junping Shi

J Adv Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD.
Xiao-Dong Zhou, Li-You Lian, Qin-Fen Chen, Seung Up Kim, Terry Cheuk-Fung Yip, Atsushi Nakajima, Junping Shi, Hirokazu Takahashi, Hiroshi Isoda

J Hepatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of high-intensity interval training on clinical parameters in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials.
Jie Fu, Chunlan Liu, Luping Yang, Binbin Zhang, Run Zhou, Junping Shi

Eur J Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Population-Based Cohort Study.
Yee Hui Yeo, Yixuan Zhu, Jingli Gao, Shanghao Liu, Wenjing Ni, Junping Shi

Aliment Pharmacol Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kupffer Cells Regulate iNKT Cells Through Il-12 to Mitigate the Extent of APAP-Induced Damage in the Liver.
Yinling Li, Shuang Wen, Jie Liu, Shuwei Li, Junping Shi

J Cell Mol Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NFATc1 facilitates hepatocellular carcinoma progression by regulating the senescence-associated secretory phenotype.
Zhaobin Chen, Liyuan Huang, Leping Ding, Congrui Zhang, Yanpeng Li, Junping Shi

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD.
Xiao-Dong Zhou, Yu-Ting Li, Seung Up Kim, Terry Cheuk-Fung Yip, Salvatore Petta, Atsushi Nakajima, Junping Shi, Hirokazu Takahashi, Hiroshi Isoda

Clin Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled study.
Yameng Sun, Cuisong Wu, Guijie Xin, Bihui Zhong, Xiaofeng Wu, Junping Shi

Hepatology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis.
Jie Li, Liang Xu, Fajuan Rui, Sally Tran, Pei-Chien Tsai, Hiroshi Abe, Yoko Yoshimaru, Shinichi Aishima, Junping Shi

Hepatology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of chronic hepatitis B concurrent with non-alcoholic fatty liver disease: a proteomics report based on clinical liver samples.
Xin Tong, Yawen Wan, Shengxia Yin, Li Shao, Renling Yao, Junping Shi

Clin Proteomics· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ELANE enhances KEAP1 protein stability and reduces NRF2-mediated ferroptosis inhibition in metabolic dysfunction-associated fatty liver disease.
Qingqing Yang, Xuan Shen, Yan Luo, Rongqing Li, Xiangrui Meng, Junping Shi

Cell Death Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis